Impaired removal of DNA interstrand cross-link in Nijmegen breakage syndrome and Fanconi anemia, but not in BRCA-defective group.
Human diseases characterized by a high sensitivity to DNA interstrand cross-links (ICL) and predisposition to malignance include Nijmegen breakage syndrome (NBS) and Fanconi anemia (FA), which is further classified to three groups: (1) FA core-complex group; (2) FA-ID complex group; and (3) breast cancer (BRCA)-defective group. The relationships between these four groups and the basic defect in ICL repair remain unclear. To study the details of ICL repair in NBS and FA, a highly sensitive PPB (psoralen-polyethylene oxide-biotin) dot blot assay was developed to provide sensitive quantitative measurements of ICL during the removal process. Studies utilizing this assay demonstrated a decreased rate of ICL removal in cells belonging to the FA core-complex group (e.g. groups A and G) and FA-ID complex group (group D2), while ICL removal was restored to normal levels after these cells were complemented with wt-FANCA, wt-FANCG and wt-FANCD2. Conversely, FA-D1 cells with a defective BRCA2 protein displayed normal ICL removal, although they were compromised with respect to recombination. This normal ICL removal rate in recombination-deficient cells was confirmed by using XRCC3-defective Chinese hamster cells, which are similarly compromised with respect to recombination and are sensitive to mitomycin C. The present study also showed that cells from patients with Nijmegen breakage syndrome were defective in ICL removal, while they were impaired in the recombination. These results indicate an obvious defect of FA and NBS in the ICL repair process, except in the BRCA-defective group, and a separate step of recombination-mediated repair pathway between the BRCA group and NBS.
Tsuchida
Ken
K
Radiation Biology Center, Kyoto University, Yoshida-Konoecho, Kyoto, Japan.
Komatsu
Kenshi
K
D000818:Animals; D024682:BRCA2 Protein / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D006224:Cricetinae; D004247:DNA / Q000378:metabolism; D004249:DNA Damage; D004260:DNA Repair; D005199:Fanconi Anemia / Q000235:genetics* / Q000378:metabolism; D052236:Fanconi Anemia Complementation Group D2 Protein / Q000378:metabolism; D006801:Humans; D051379:Mice; D049932:Nijmegen Breakage Syndrome / Q000235:genetics* / Q000378:metabolism
D024682:BRCA2 Protein; D052236:Fanconi Anemia Complementation Group D2 Protein; D004247:DNA
Mutat Res. 1984 Jan;133(1):51-85
6363909
Nat Cell Biol. 2002 Dec;4(12):913-20
12447395
Lancet Oncol. 2001 Aug;2(8):483-90
11905724
Cancer Cell. 2005 Sep;8(3):255-65
16153896
Mol Cell Biol. 2001 Feb;21(3):713-20
11154259
Carcinogenesis. 1996 Dec;17(12):2597-602
9006094
Cancer Treat Res. 2002;112:109-28
12481714
Genes Dev. 2005 Dec 15;19(24):2925-40
16357213
Nat Genet. 2005 Sep;37(9):934-5
16116423
Cell. 2007 Apr 20;129(2):289-301
17412408
Nat Rev Cancer. 2003 Jan;3(1):23-34
12509764
Mol Cell. 2006 Jun 23;22(6):719-729
16793542
Nat Genet. 2007 Feb;39(2):159-61
17200672
Mol Cell Biol. 2004 Jan;24(1):123-34
14673148
J Biol Chem. 1997 Feb 7;272(6):3833-7
9013642
Blood. 2002 Oct 1;100(7):2414-20
12239151
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):855-61
15279770
Mol Cell. 2001 Feb;7(2):249-62
11239454
Nucleic Acids Res. 2000 Dec 1;28(23):4800-4
11095693
Biochemistry. 1988 Aug 23;27(17):6332-8
3219339
Mol Cell Biol. 2000 Nov;20(21):7980-90
11027268
Cancer Res. 1985 Apr;45(4):1737-43
3919945
EMBO J. 2006 Oct 18;25(20):4921-32
17036055
Mol Cell Biol. 2003 Jan;23(2):754-61
12509472
Mutat Res. 1991 Sep;255(2):111-21
1922147
Mol Cell Biol. 2003 Aug;23(15):5421-30
12861027
Biochemistry. 1988 Jul 12;27(14):5174-8
3167039
DNA Repair (Amst). 2007 Nov;6(11):1670-8
17669695
Nucleic Acids Res. 2007;35(11):3733-40
17517774
Mol Cell Biol. 2004 Jul;24(13):5776-87
15199134
Mol Cell. 2003 Jul;12(1):247-54
12887909
Nature. 2002 Nov 7;420(6911):93-8
12422221
Nat Genet. 2007 Feb;39(2):162-4
17200671
Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1110-5
15650050
Cell Cycle. 2004 Feb;3(2):179-81
14712086
Mol Cell. 1998 May;1(6):783-93
9660962
Nucleic Acids Res. 1994 Aug 11;22(15):3005-10
8065913
Mutat Res. 2006 Feb 22;594(1-2):39-48
16154163
DNA Repair (Amst). 2006 May 10;5(5):566-74
16569514
Am J Hum Genet. 2007 May;80(5):895-910
17436244
Cancer Chemother Pharmacol. 1996;38(5):406-16
8765433
J Biol Chem. 2000 Aug 25;275(34):26632-6
10882712
Nucleic Acids Res. 2001 Jul 1;29(13):E66-6
11433042
Mol Cell. 2004 Aug 27;15(4):607-20
15327776
Mutat Res. 2001 Sep 4;486(4):217-47
11516927
J Biol Chem. 1998 Aug 21;273(34):21482-8
9705276
Biochemistry. 1982 Mar 2;21(5):861-71
7074056